These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


590 related items for PubMed ID: 19409827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F.
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 5. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A, Catlett JP.
    South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current therapies in primary immune thrombocytopenia.
    Pels SG.
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [Abstract] [Full Text] [Related]

  • 8. [New treatment methods for autoimmune thrombocytopenia].
    Koene HR.
    Ned Tijdschr Geneeskd; 2007 Nov 24; 151(47):2609-14. PubMed ID: 18161261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Idiopathic thrombocytopenic purpura (ITP)].
    Kashiwagi H, Tomiyama Y.
    Rinsho Ketsueki; 2012 Feb 24; 53(2):178-84. PubMed ID: 22450577
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Current treatment of primary immune thrombocytopenia].
    Lozano ML, Vicente V.
    Med Clin (Barc); 2014 May 06; 142(9):399-405. PubMed ID: 23809409
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D.
    Hematology; 2012 Apr 06; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of immune thrombocytopenic purpura in adults.
    Bussel J.
    Semin Hematol; 2006 Jul 06; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
    [Abstract] [Full Text] [Related]

  • 20. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN, Kozuch P, Varma M.
    Clin Adv Hematol Oncol; 2006 Feb 06; 4(2):136-44, 153. PubMed ID: 16728922
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.